Alexandra MacLean - Chief Executive Officer, Director at Avenue Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
ATXI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Alexandra MacLean since 11/5/2023

Holdings reported by Alexandra MacLean for Avenue Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
COMMON STOCK, PAR VALUE $0.0001 170K $23.8K $0.14 Sep 23, 2024 Direct

Transactions reported by Alexandra MacLean for Avenue Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.